alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › pharmacogenomics

pharmacogenomics

3 studies tagged pharmacogenomics, dated 2000-07-01 to 2022-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development 2022-01-01
  2. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs 2021-04-08
  3. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics 2000-07-01

Studies

3 studies carry this tag.

Date range

2000 to 2022

Top journals

  • Drugs of today (Barcelona, Spain : 1998) 1
  • Methods in molecular biology (Clifton, N.J.) 1
  • Molecular psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Methods in molecular biology (Clifton, N.J.) 2022-01-01 Drug development

    Approximately 20% of direct costs are associated with pharmacological treatment.

  2. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Molecular psychiatry 2021-04-08 Drug development

    The development of blood tests, as well as matching of patients with existing and new treatments, in a precise, personalized and preventive fashion, would make a significant difference at an individual and societal level.

  3. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Drugs of today (Barcelona, Spain : 1998) 2000-07-01 Drug development

    Potential therapeutic strategies for AD treatment include palliative treatment with nonspecific neuroprotecting agents, symptomatic treatment with psychotropic drugs for noncognitive symptoms, cognitive treatment with cognition enhancers, substitutive treatment with cholinergic enhancers to improve memory deficits, multifactorial treatment using several drugs in combination and etiopathogenic treatment designed to regulate molecular factors potentially associated with AD pathogenesis.

All topic tags with their study counts